Hexamethylene bisacetamide in myelodysplastic syndrome: effect of five-day exposure to maximal therapeutic concentrations.

Rowinsky, E K

Hexamethylene bisacetamide in myelodysplastic syndrome: effect of five-day exposure to maximal therapeutic concentrations. [electronic resource] - Leukemia Jun 1992 - 526-34 p. digital

Publication Type: Journal Article; Research Support, U.S. Gov't, P.H.S.

0887-6924


Acetamides--administration & dosage
Adult
Aged
Algorithms
Cell Division--drug effects
Depression, Chemical
Drug Administration Schedule
Female
Hematinics--administration & dosage
Hematopoietic Stem Cells--drug effects
Humans
Leukopenia--chemically induced
Male
Middle Aged
Myelodysplastic Syndromes--blood
Survival Rate
Thrombocytopenia--chemically induced